Author

V. Planas-Bielsa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Ecology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:ecology & biodiversity· 2 Approach:experimental assay· 2 Organism:non-human primate· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

A. Houstin· 2 shared B. Fabry· 2 shared C. Le Bohec· 2 shared D. P. Zitterbart· 2 shared A. Ancel· 1 shared A. Vandenberghe· 1 shared A. Winterl· 1 shared C. Montemagno· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersEcology

A. Houstin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Biologging of emperor penguins - attachment techniques and associated deployment performance

A. Houstin, D. P. Zitterbart, A. Winterl, S. Richter, V. Planas-Bielsa, D. Chevallier, A. Ancel, J. Fournier, B. Fabry, C. Le Bohec

This paper evaluates biologging techniques for emperor penguins, finding that traditional gluing methods harm birds and proposing alternative attachment methods with better deployment success.

bioRxiv · Jun 8, 2021Ecology

Juvenile emperor penguin range calls for extended conservation measures in the Southern Ocean

A. Houstin, D. P. Zitterbart, K. Heerah, O. Eisen, V. Planas-Bielsa, B. Fabry, C. Le Bohec

The paper shows that juvenile emperor penguins spend most of their time outside current marine protected areas, highlighting the need for expanded conservation measures.

bioRxiv · Apr 6, 2021Ecology

The antiangiogenic compound axitinib demonstrates low toxicity and anti-tumoral effects against medulloblastoma

M. Pagnuzzi-Boncompagni, V. Picco, V. Vial, V. Planas-Bielsa, A. Vandenberghe, R. Grepin, J. Durivault, C. Montemagno, S. Martial, J. Doyen, J. Gavard, G. Pages

This study evaluates axitinib's efficacy and safety in medulloblastoma, finding it has low toxicity and anti-tumoral effects in preclinical models and poor prognosis association in public databases.

bioRxiv · Sep 18, 2020 · PreprintCancer Biology